Company Analysis Hangzhou Tigermed Consulting Co., Ltd
1. Summary
Advantages
- The stock's return over the last year (-19.53%) is higher than the sector average (-36.11%).
- Current debt level 0% is below 100% and has decreased over 5 years from 12.66%.
Disadvantages
- Price (49.91 Β₯) is higher than fair price (29.89 Β₯)
- Dividends (0%) are below the sector average (1.83%).
- The company's current efficiency (ROE=10.19%) is lower than the sector average (ROE=11.95%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Hangzhou Tigermed Consulting Co., Ltd | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1.4% | -4.6% | -0.4% |
| 90 days | -6.7% | -16% | 16.2% |
| 1 year | -19.5% | -36.1% | 38.3% |
300347 vs Sector: Hangzhou Tigermed Consulting Co., Ltd has outperformed the "Healthcare" sector by 16.58% over the past year.
300347 vs Market: Hangzhou Tigermed Consulting Co., Ltd has significantly underperformed the market by -57.82% over the past year.
Stable price: 300347 is not significantly more volatile than the rest of the market on "Shenzhen Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 300347 with weekly volatility of -0.3755% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (49.91 Β₯) is higher than the fair price (29.89 Β₯).
Price is higher than fair: The current price (49.91 Β₯) is 40.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (27.81) is lower than that of the sector as a whole (69.4).
P/E vs Market: The company's P/E (27.81) is lower than that of the market as a whole (63.57).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.87) is lower than that of the sector as a whole (3.96).
P/BV vs Market: The company's P/BV (2.87) is lower than that of the market as a whole (3.79).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (8.09) is higher than that of the sector as a whole (6.51).
P/S vs Market: The company's P/S indicator (8.09) is higher than that of the market as a whole (5.87).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (18.94) is higher than that of the sector as a whole (11.85).
EV/Ebitda vs Market: The company's EV/Ebitda (18.94) is lower than that of the market as a whole (25.54).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 3.55% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (3.55%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (10.19%) is lower than that of the sector as a whole (11.95%).
ROE vs Market: The company's ROE (10.19%) is higher than that of the market as a whole (9.38%).
5.5. ROA
ROA vs Sector: The company's ROA (4.08%) is lower than that of the sector as a whole (5.4%).
ROA vs Market: The company's ROA (4.08%) is higher than that of the market as a whole (3.95%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.83%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 0% has been growing over the last 5 years. Growth over 6 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (21.01%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
